Navigating the digital health landscape from artificial intelligence-driven molecular subtyping towards optimized rare sarcoma trial design.

Abstract

Authors

• Yuning Wang
  Clinical Department of Surgery, Chinese People's Liberation Army General Hospital (301 Hospital), 28 Fuxing Rd, 100853, Beijing, China.
• Shuhang Wang
• Ning Li
  Department of Respiratory and Critical Care Medicine, Center for Respiratory Medicine, the Fourth Affiliated Hospital of School of Medicine, and International School of Medicine, International Institutes of Medicine, Zhejiang University, Yiwu, China.

Keywords

No keywords available for this article.

External Resources